Css LLC Galapagos Nv Call Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$42.27 - $57.6 $1.74 Million - $2.37 Million	-41,200 Reduced 80.47%	10,000 $426,000
Q2 2022 Aug 15, 2022	BUY	$52.3 - $71.59 $298,110 - $408,063	5,700 Added 12.53%	51,200 $2.86 Million
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $1.77 Million - $2.36 Million	34,500 Added 313.64%	45,500 $2.82 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $282,180 - $342,720	6,000 Added 120.0%	11,000 $607,000
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $2.6 Million - $3.5 Million	-49,800 Reduced 90.88%	5,000 $263,000
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $1.31 Million - $1.58 Million	19,000 Added 53.07%	54,800 $3.78 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $2.73 Million - $4.01 Million	35,800 New	35,800 $2.76 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.85B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.